Skip to content

Research about gestational diabetes mellitus based on continuous glucose monitoring

Research about gestational diabetes mellitus based on continuous glucose monitoring - mH-GDm trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093401
Enrollment
Unknown
Registered
2024-12-04
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus

Interventions

Clinical standard care group based on finger-prick testing for self-mornitoring:Patients allocated to standard care will receive a finger-stick testing toolkit certified as medical device. They will u
Experimental group based on continuous blood glucose meters for self-monitoring:In the experimental care group, the patient will be provided a CGM toolkit certified as a medical device. The patient wi

Sponsors

Department of Public Health, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 18-45 years; Normal singleton pregnant women < 35 weeks and 0 days of pregnancy; Diagnosis of GDM by 75 g oral glucose tolerance test during 24-28 weeks of gestation; Pregnant women who do not require immediate insulin therapy after the diagnosis of GDM are monitored 2 hours after a meal and one week after confirmation.

Exclusion criteria

Exclusion criteria: Pregnant women with a history of diabetes mellitus; Pregnant women with cardiopulmonary disease or exercise restriction contraindicated by exercise intervention, gastrointestinal disease contraindicated by nutritional intervention, psychiatric illness requiring treatment, other serious illness contraindicated by lifestyle intervention; Pregnant women who do not have compliance as assessed by the Principal Investigator or Clinical Coordinator.

Design outcomes

Primary

MeasureTime frame
Mbined proportion of caesarean section (C-section) deliveries, shoulder dystocia occurrences and macrosomia incidences at delivery;

Secondary

MeasureTime frame
HbA1c;Change in blood glucose;Fasting blood glucose;Preprandial blood glucose;Postprandial blood glucose;Time from recruitment to initiation of treatment (in weeks);Maternal body weight;Maternal BMI;Gestational age;Incidence of gestational hypertension or preeclampsia;Neonatal body weight;Incidence of neonatal hypoglycemia;Admission to the neonatal ICU;

Countries

China

Contacts

Public ContactYangYang

Department of Public Health, Shanghai Jiaotong University School of Medicine

emma002@sjtu.edu.cn+86 138 1792 3383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026